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Abstract
Phosphoinoisitide dependent kinase l (PDK1) is proposed to phosphorylate a key threonine residue
within the catalytic domain of the protein kinase C (PKC) superfamily that controls the stability and
catalytic competence of these kinases. Hence, in PDK1-null embryonic stem cells intracellular levels of
PKCα, PKCβ1, PKCγ, and PKCε are strikingly reduced. Although PDK1-null cells have reduced
endogenous PKC levels they are not completely devoid of PKCs and the integrity of downstream PKC
effector pathways in the absence of PDK1 has not been determined. In the present report, the PDK1
requirement for controlling the phosphorylation and activity of a well characterised substrate for
PKCs, the serine kinase protein kinase D, has been examined. The data show that in embryonic stem
cells and thymocytes loss of PDK1 does not prevent PKC-mediated phosphorylation and activation of
protein kinase D. These results reveal that loss of PDK1 does not functionally inactivate all
PKC-mediated signal transduction.
Abbreviations: ES cell, embryonic stem cell; p90RSK, p90 ribosomal S6 kinase; PDK1,
3′-phosphoinositide-dependent protein kinase-1; PKC, protein kinase C; PKD, protein kinase D;
S6K1, 70-kilodalton ribosomal S6 kinase 1
Keywords: PDK1, PKD, PKC
1. Introduction
Phosphoinoisitide dependent kinase l (PDK1) phosphorylates a key threonine residue within the
catalytic domain of a number of AGC family kinases, including diacylglycerol-regulated kinases of the
protein kinase C (PKC) superfamily and phosphatidyl inositol-3 kinase (PI3K)-controlled serine
kinases such as Akt/PKB and the 70-kilodalton ribosomal S6 kinase 1 (S6K1) [1]. PDK1-mediated
phosphorylation of many of these AGC kinases is essential for their activation. Accordingly, deletion
of PDK1 by homologous recombination removes one of the rate-limiting regulators of multiple serine
kinases and causes embryonic lethality [2]. To circumvent this prenatal death and explore the role of
PDK1 in different tissues, mice expressing PDK1 alleles flanked with the loxP Cre excision sequence
(PDK1  mice) have been generated. These were first used to achieve muscle specific
deletion of PDK1, producing mice that die early with severe defects in cardiac function [3]. The
importance of PDK1 for T lymphocyte biology has also been explored by looking at T cell development
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following T lineage specific deletion of PDK1. These studies showed that deletion of PDK1 in T cell
progenitors in the thymus results in a block in T cell differentiation, indicating that PDK1 has
essential functions in T lymphocyte development [4].
The importance of PDK1 for T cell development in the thymus focuses attention on the identification
of the PDK1 substrates directly involved in mediating the unique and non-redundant functions of this
kinase in vivo. In this context, studies of mouse embryonic stem cells in which both PDK1 alleles have
been deleted have shown that PDK1 is necessary for T-loop phosphorylation, and catalytic activity, of
the AGC kinases Akt/PKB, S6K1 and p90 ribosomal S6 kinase (p90RSK) [5]. However, PDK1 is not
required for the phosphorylation and activation of other AGC kinases such as PKA or AMPK [5].
One very important subfamily of AGC kinases that can be regulated by PDK1 are the protein kinase C
enzymes. There are multiple isoforms of PKC: the classical PKCs (α, βI, βII and γ) which are regulated
by calcium, diacylglycerol (DAG) and phospholipids; novel PKCs (δ, ε, η and θ) which are regulated
by DAG and phospholipids; and the atypical PKCs (ζ and λ) which are insensitive to both calcium and
DAG. The catalytic domain of PKCs have a conserved T-loop motif that is a substrate for PDK1, and it
has been proposed that PDK1 is responsible for T-loop phosphorylation of the various PKC isoforms
[6–8]. PDK1-mediated T-loop phosphorylation of PKCs is proposed to stabilize protein expression by
acting as a priming signal that enables PKCs to achieve catalytic maturity [6,7]. Here, PDK1 docks to
a hydrophobic motif in the C-terminus of newly synthesised PKC enzymes, enabling it to
phosphorylate their T-loop sites. Following T-loop phosphorylation, PDK1 disengages enabling PKCs
to autophosphorylate their C-terminal hydrophobic motifs and achieve catalytic maturity [9–11]. Once
mature, PKCs remain inactive due to autoinhibition from their pseudosubstrate motifs and are only
activated following the generation of second messengers, such as diacylglycerol and calcium.
The release of PDK1 from PKCs is rate limiting and so PDK1 is responsible for controlling the amount
of mature/catalytically competent PKCs expressed in cells [11]. Hence, in the absence of PDK1,
intracellular levels of PKCα, PKCβ1, PKCγ, and PKCε are strikingly reduced [6,12]. PKCξ levels are
similar in wild-type and PDK1-null embryonic stem cell (ES cells) although PKCξ is not
phosphorylated on its T-loop Thr410 site in the absence of PDK1 [6,13]. PKCδ expression is also
reduced in PDK1-null cells [6,12] although there was still phosphorylation of the PKCδ T-loop site
Thr505 in the residual pool of PKCδ still present in PDK1-null cells [13]. Moreover, there is some
evidence in the literature that T-loop phosphorylation is not absolutely critical for PKCδ catalytic
activity, since a bacterially-expressed Thr505A PKCδ mutant protein retains some activity in vitro
[14]. Of note, a glutamic acid residue at position 500 within the PKCδ activation loop, which is
important for catalytic activity [15], could potentially compensate for the lack of PKCδ T-loop
phosphorylation in PDK1-null cells.
These studies support the hypothesis that PDK1 has an important role in regulating PKC
phosphorylation and stability. However, it has not been shown unequivocally that the reduced levels
of PKCs in PDK1-null cells abrogate PKC-mediated cellular responses. In this context, it has been
shown that in the absence of PDK1 there is loss of Akt/PKB and S6K1 T-loop phosphorylation and a
corresponding inability of cells to regulate phosphorylation of Akt/PKB or S6K1 substrates [5]. There
is thus confidence that Akt/PKB and S6K1 function is defective in PDK1-null cells. This has not been
determined for the PKCs because although PDK1-null cells have reduced endogenous PKC levels the
integrity of downstream PKC effector pathways in PDK1-null cells has not been determined.
One well characterised target for novel PKCs is the serine kinase protein kinase D (PKD). Activation
of PKD requires the phosphorylation of two key serine residues within the catalytic domain [16,17].
These residues are absolutely conserved through evolution from C. elegans to man and are substrates
for novel PKCs. The activation of PKCs is thus required for PKD activation in a variety of cell lineages
in response to a number of different stimuli [16,17]. For example, it has been demonstrated that PKD
activity in lymphocytes is regulated by PKC-mediated phosphorylation of its catalytic domain [18,19]
and phosphorylation of the PKD catalytic domain is reduced in PKCβ-deficient spleenocytes [20]. It
would therefore be expected that PKD would remain inactive if PKCs cannot achieve catalytic
maturity in PDK1-null cells. In support of this hypothesis, previous work has established that
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co-expression of PDK1 and the novel PKCε isoform, together with PKD, enhances PKD activity [21].
The hypothesis that PKD activation is dependent on PDK1 has not been fully investigated and is
important to address as it is one way to assess whether there is residual functional PKC activity in
PDK1-null cells. Accordingly, the objective of the present study was to examine whether loss of PDK1
results in loss of the PKC signalling pathway that regulates PKD.
2. Results and discussion
2.1. Activation of protein kinase D in PDK1  thymocytes
To investigate the impact of PDK1 loss on protein kinase D activation in PDK1 deficient T
lymphocytes, mice expressing PDK1 alleles flanked with the loxP Cre excision sequence
(PDK1 ) were bred with transgenic mice expressing Cre recombinase under the control of
the proximal p56lck promoter which induces expression of Cre in T cell progenitors in the thymus. It
has been shown previously that in LckCre PDK1  mice PDK1 is deleted in pre-T cells,
preventing normal T cell development [4]. To explore the role of PDK1 in the regulation of PKD
activity, wild-type or PDK1  pre-T cells were isolated and left unstimulated, stimulated with a
crosslinking α-CD3 antibody (to activate preTCR signalling) or were stimulated with the phorbol
ester PdBu (a diacylglycerol mimetic which activates classical/novel PKCs), as indicated. PKD
catalytic activity was monitored using an antisera that recognises PKD molecules that are
autophosphorylated on Ser916 [22]. The data (Fig. 1) show that in quiescent wild-type thymocytes
PKD is not autophosphorylated on Ser916 whereas α-CD3 or PdBu stimulation strongly induced PKD
catalytic activity, as shown by increased Ser916 autophosphorylation. The results also show that both
α-CD3 and PdBu treatment induce strong PKD Ser916 autophosphorylation in PDK1  pre-T cells (
Fig. 1). PKD activation is dependent on PKC-mediated phosphorylation of two key serine residues
(Ser744/S748) within the PKD catalytic domain and as shown in Fig. 1, PKD is phosphorylated on
Ser744/S748 following α-CD3 or PdBu activation in both wild-type and PDK1  pre-T cells.
The phosphorylation and activation of PKD in PDK1  pre-T cells argues that these cells still contain
a functional, catalytically competent PKC(s) that is able to respond to diacylglycerol/phorbol ester
signals. RNAi experiments have demonstrated that PKCε in Swiss 3T3 cells or PKCδ in HeLa cells are
the PKC isoforms responsible for serine phosphorylation (Ser744/S748) within the PKD activation
loop [23,24]. PKCδ has been shown to be residually phosphorylated on its T-loop Thr505 site in
PDK1-null ES cells [13]. We therefore examined the phosphorylation status of the PKCδ T-loop site,
Thr505, in PDK1  pre-T cells. The data in Fig. 1 show basal phosphorylation of PKCδ Thr505 in
wild-type pre-T cells and also show that significant phosphorylation of PKCδ on Thr505 in retained in
PDK1  pre-T cells. In contrast, as previously demonstrated, PDK1  pre-T cells have lost activity of
the PKB/S6K1 signalling pathway that controls the phosphorylation of the ribosomal S6 subunit on
Ser235/236 [4,25]. The data in Fig. 1 also explore the impact of PDK1 loss on the T-loop
phosphorylation of p90RSK1 and PRK1. The data show Western blot analysis of wild type and PDK1
null pre-T cells with a phospho-specific antibody against Ser227 in p90RSK1 and show that this site
is basally phosphorylated in wild-type pre-T cells but is not phosphorylated in PDK1-null pre-T cells.
Similarly, basal phosphorylation of PRK1 on its Thr774 T-loop site is substantially reduced in
PDK1-null pre-T cells. Thus, PDK1-null pre-T cells show defective activation of some, but not all, AGC
family kinases: regulation of a PKC–PKD signalling pathway remains intact in these cells.
2.2. Activation of protein kinase D in PDK1  ES cells
The experiments in Fig. 1 show that PDK1 is not essential for PKD activation in thymocytes. To probe
further the involvement of PDK1 in the regulation of PKC–PKD signalling, experiments in wild-type
and PDK1  mouse embryonic stem cells were performed. Western blot analysis of wild-type and
PDK1  ES cells with a PKCδ Thr505 phosphospecific antisera confirm that PKCδ Thr505
phosphorylation is detectable, albeit slightly reduced, in PDK1-null versus wild-type ES cells (Fig. 2
A–C). To probe PKD activity, cells were left unstimulated or activated by exposure to serum or phorbol
ester as indicated and PKD catalytic activity monitored using the pSer916 antisera. In quiescent,
wild-type ES cells, PKD was not autophosphorylated on Ser916 but both serum and PdBu stimulation
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strongly and rapidly induced PKD activity as measured by increased Ser916 autophosphorylation (
Fig. 2A and B). Serum or PdBu stimulation also induced PKD activity in the PDK1  ES cells (Fig. 2A
and B) whereas p90RSK1 T-loop phosphorylation (Ser227) was basally detectable in wild-type ES
cells but not in the PDK1  ES cells (Fig. 3). S6K1 signalling was also abrogated, as expected, in the
PDK1  ES cells, as shown by the lack of phosphorylation of its substrate, the S6 ribosomal protein
subunit (Fig. 2B).
The ability of serum and phorbol esters to activate PKD in PDK1-null ES cells is an indication that
there is residual, catalytically competent PKC in these cells. PKC-mediated activation of PKD can be
prevented by the PKC inhibitor GF109203X [17]. Therefore, the effects of GF109203X, on PKD
activation in wild-type or PDK1  ES cells was examined. The data (Fig. 3) show that PKD was
phosphorylated on Ser916 in activated PDK1  and PDK1  cells but that PKD autophosphorylation
on Ser916 was prevented by prior treatment of both cell types with GF109203X.
3. Concluding remarks
Loss of PDK1 in ES cells causes a reduction in levels of PKCα, β , γ, δ, and ε [6,12] but it was not
resolved whether the residual PKC in these cells is functional. As discussed above, there is a large
body of evidence that PKD activation is mediated by novel PKCs such as PKCδ and ε and it has
previously been proposed that PDK1 is required for activation of PKD [21], reflecting the requirement
of PDK1 for phosphorylation of the key priming T-loop phosphorylation sites in PKCs. However, the
present study shows that the hypothesis that PKD activation is dependent on PDK1 is incorrect. The
reason this model fails is that there is not a complete loss of PKC activity in the absence of PDK1. We
show that in PDK1-null pre-T cells PKCδ is still phosphorylated on its T-loop site Thr505; hence
activation of pre-T cells with phorbol esters can still induce phosphorylation of PKD on its PKC
substrate sequences Ser744/S748, inducing PKD activation and subsequent autophosphorylation on
Ser916. In addition, the present data show that PKD can also be activated by phorbol esters or serum
stimulation of PDK1-null ES cells in a PKC-regulated manner. Thus, the present results showing
activation of PKD in PDK1  cells is evidence that at least one PKC-mediated signalling pathway is
intact in the absence of PDK1.
While loss of PDK1 does not prevent the activation of PKD, the issue of whether the efficiency of PKD
activation is affected in PDK1-null cells requires further experimentation. While robust activation of
PKD signalling is observed in PDK1-null ES cells and pre-T cells in response to phorbol esters or CD3
crosslinking we cannot exclude the possibility that PKD activation may be compromised in PDK1-null
mature peripheral T cells during physiological peptide:MHC stimulation, however these experiments
await the development of genetic models to test this.
In summary, PDK1 is essential for pre-T cell development and its loss is associated with loss of
PKB/S6K1-mediated signal transduction [4,25]. The present results now show loss of p90RSK and
PRK1 T-loop phosphorylation in PDK1  pre-T cells but reveal that the PKCδ T-loop site Thr505 is
still phosphorylated in PDK1-null pre-T cells. It has been proposed that the Thr505 T-loop site in
PKCδ (as well as the corresponding T-loop site in PKCθ, [26]) can be autophosphorylated, which may
explain why PKCδ Thr505 is still phosphorylated in the PDK1-null cells. Alternatively the present
results could argue for the existence of another PKCδ priming kinase in developing thymocytes.
Whatever the molecular basis for the continued phosphorylation of PKCδ following the loss of PDK1,
the present results show that there is still residual functional PKC activity once PDK1 is lost. Hence,
the importance of PDK1 for T cell development must reflect the requirement for PDK1 mediated
phosphorylation of other members of the AGC serine kinase family, such as Akt/PKB, S6K1 or
p90RSK, since phosphorylation and activity of these kinases is strictly dependent on PDK1
expression.
4. Materials and methods
4.1. Cell preparation and stimulation
PDK1  and PDK1  murine embryonic stem cells [5] were grown on gelatinised tissue culture
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plates in Knockout DMEM supplemented with 10% knockout serum replacement, 15% foetal bovine
serum (Hyclone), 0.1 mM non-essential amino acids, antibiotics (100 U/ml penicillin G, 100 µg/ml
streptomycin and 1 µg/ml ciprofloxacin [Bayer Pharmaceuticals]), 2 mM L-glutamine, 1 mM sodium
pyruvate, 0.1 mM β-mercaptoethanol and 25 ng/ml murine leukaemia inhibitory factor (LIF).
4.2. Mice
All mice used were between 5 and 7 weeks of age. Mice were bred and maintained in specific
pathogen-free conditions and animal experimentation was approved by Home Office project license
PPL60/3116. T-PDK1  mice were generated by crossing mice with PDK1 floxed alleles
(PDK1 ) with mice expressing Cre recombinase under the control of the p56  promoter to
ablate expression of PDK1 in T cells [2,4]. Control mice used for analyses of T-PDK1  mice were
age-matched phenotypically normal littermates.
4.3. Purification of thymocyte subpopulations
Antibodies conjugated to fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin
(APC) and biotin were obtained from PharMingen. Cells were stained for surface expression of the
following markers: CD4, CD8, CD25, CD44, CD3ε, γδ, B220, and Thy1. The DN4 subpopulation were
defined by their cell surface marker expression and subsequently sorted using a Vantage cell sorter
(Becton Dickinson) or AutoMacs magnetic cell sorter (Miltenyi Biotec).
4.4. Cell lysis and Western blot analysis
Cells were lysed for 10 min at 4 °C (20 × 10  cells/ml) using buffer: 100 mM HEPES, pH 7.4, 150 mM
NaCl, 1% NP40, 20 mM sodium fluoride, 20 mM iodoacetamide, 2 µM EDTA, 1 mM sodium
orthovanadate, 2 µg/ml pepstatin A, 2 µg/ml leupeptin, 2 µg/ml chymostatin, 2 µg/ml antipain,
40 mM β-glycerophosphate and 1 mM phenylmethylsulfonylflouride. Soluble proteins were
concentrated by precipitation with 1.5 vol. of acetone and separated by 8% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), transferred to polyvinylidene difluoride membranes
and detected by Western blot analysis with the indicated antibodies (Cell Signalling Technology).
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Fig. 1
PKD activity in PKD1-null pre-T cells. DN4 thymocytes, purified from wild-type (PDK1 ) and
LckCre PKD1  (PKD1 ) mice, were left unstimulated (−) or were treated with PdBu
(20 ng/ml) for 10 min before lysis. Protein extracts from 1 × 10  cells (unless otherwise indicated)
were separated by SDS–PAGE and analyzed by Western blotting with the indicated antibodies. PKD
activity was assessed using a phospho-specific antibody against its Ser916 autophosphorylation site.
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Fig. 2
PKD activity in PKD1-null embryonic stem cells. (A) Serum-starved wild-type (PKD1 ) and
PKD1  murine ES cells were left unstimulated (−) or were treated with PdBu (20 ng/ml) or serum
(10%) for 10 min before lysis. Protein extracts were separated by SDS–PAGE and analyzed by Western
blotting with the indicated antibodies. (B) Serum starved wild-type and PKD1  murine ES cells
were left unstimulated (−) or were treated with/without serum (10%) for varying times before lysis.
Protein extracts (200 µg) were separated by SDS–PAGE and analyzed by Western blotting with the
indicated antibodies. (C) Protein extracts (200–12 µg) from wild-type and PKD1  murine ES cells
were separated by SDS–PAGE and analyzed by Western blotting with a pThr505 PKCδ antibody.
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Fig. 3
PKD activity in PKD1-null ES cells is sensitive to the PKC inhibitor, GF109203X. Wild-type and
PKD1  murine ES cells were pretreated with 5 µM GF109203X (GF) for 20 min, then left
unstimulated (−) or were treated with PdBu (20 ng/ml) for 10 min before lysis. Protein extracts
(200 µg) were separated by SDS–PAGE and analyzed by Western blotting with the indicated
antibodies.
−/−
Phosphoinositide-dependent protein kinase-1 (PDK1)-independent activation of the protein kinase C substrate, protein kinase D
10 of 10
